The HealthTech Activator (HTA) is a coordinated, ecosystem-wide support mechanism for early-stage founders and companies in NZ’s healthtech sector.
The HTA makes it easier for healthtech companies to find and access the support they need to turn their health innovations into successful businesses. In doing so, it aims to advance, de-risk and accelerate the commercialisation of innovation in NZ’s healthtech ecosystem.
The HealthTech Activator directory is provided to connect members of the healthtech sector to service providers, funding organisations, and networks to support their commercialisation journey.
The latest news from the NZ healthtech sector, including an upcoming HTA webinar, a blog covering Callaghan Innovation's Tech Incubator programme, and more...
The latest news from the NZ healthtech sector, including an upcoming HTA webinar, a blog covering Callaghan Innovation's Tech Incubator programme, and more...
In this month’s blog, the HTA team introduces Callaghan Innovation’s wider product portfolio and explores the Tech Incubator programme in greater detail.
In this month’s blog, the HTA team introduces Callaghan Innovation’s wider product portfolio and explores the Tech Incubator programme in greater detail.
The latest news from the NZ healthtech sector, including KiwiNet Awards, upcoming events, a blog on health economics, and more...
The latest news from the NZ healthtech sector, including KiwiNet Awards, upcoming events, a blog on health economics, and more...
.png)
This webinar will provide participants with an overview of some of the approaches used by decision makers in key markets to evaluate a novel health technology, and reviews some of the trends that healthtech companies should be aware of.
This webinar will provide participants with an overview of some of the approaches used by decision makers in key markets to evaluate a novel health technology, and reviews some of the trends that healthtech companies should be aware of.
-p-500.png)
Join the CMDT and Liverpool Innovation Precinct for this Australia-New Zealand BioBridge Event to hear from Dr Alys Clark of the ABI, Tara Croft of Baymatob, and Jenny Kruger of JunoFem.
Join the CMDT and Liverpool Innovation Precinct for this Australia-New Zealand BioBridge Event to hear from Dr Alys Clark of the ABI, Tara Croft of Baymatob, and Jenny Kruger of JunoFem.
.png)
This regulatory workshop is provided in collaboration with Te Tītoki Mataora, and has moved online for those unable to attend in-person in Auckland. Aimed at pre-spinout research groups and early-stage startups, this workshop covers the fundamentals of quality and regulatory considerations for medical devices.
This regulatory workshop is provided in collaboration with Te Tītoki Mataora, and has moved online for those unable to attend in-person in Auckland. Aimed at pre-spinout research groups and early-stage startups, this workshop covers the fundamentals of quality and regulatory considerations for medical devices.
